Dark

KALV
KalVista Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Jul 3, 2025

11.98USD+1.698%(+0.20)338,543

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

595.59M

CEO

Thomas Crockett

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Sep 3, 2025 (58d)

Last Split

Nov 22, 20161for14reverse

XENT EYEG KOOL SNOA XLV

KALV Stats

Avg. Vol. 10 Day

1,240,157

Avg. Vol. 30 Day

939,880

Employees

Market Cap

595,593,319

Shares Out.

49,715,636

On/Off Exchange

52%/48%

6 Month Beta

0.72

1 Year Beta

0.92

2 Year Beta

0.83

3 Year Beta

0.66

52 Week Low

7.30

52 Week High

15.50

SMA50

12.45

SMA200

10.92

1 Week

+5.97%

1 Month

-16.60%

3 Month

+4.17%

6 Month

+38.02%

1 Year

+1.61%

2 Year

+33.86%

5 Year

-5.00%

Profile

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

KALV Stock Summary

KalVista Pharmaceuticals, Inc. Common Stock (NASDAQ:KALV) stock price today is $11.98, and today's volume is 338,543. KALV is up 1.698% today. The 30 day average volume is 939,880. KALV market cap is 595.59M with 49,715,636 shares outstanding.